The landscape of weight management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatide and Retatrutide represent key advancements; Tirzepatide already demonstrating https://tirzepatide40mg194483.wikimidpoint.com/user